Objective To investigate the clinical features of acute pancreatitis(AP) with metabolic syndrome(MS) and the influencing factors for prognosis.Methods A retrospective analysis was performed for the clinical data of 590 patients with AP who were admitted to The Affiliated Hospital of Southwest Medical University from January 2013 to January 2019,and according the presence or absence of MS,they were divided into MS group with 178 patients and non-MS group with 412 patients and basic clinical features were compared between the two groups.According to the severity of AP,they were divided into mild acute pancreatitis(MAP) group with 317 patients,moderate-severe acute pancreatitis(MSAP) group with 171 patients,and severe acute pancreatitis(SAP) group with 102 patients,and the component indicators of MS were compared between the three groups.The t-test was used for comparison of normally distributed continuous data between two groups,and a one-way analysis of variance was used for comparison between multiple groups;the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups,and the Kruskal-Wallis H test was used for comparison between multiple groups;Bonferroni correction was used for further comparison between two groups.The chi-square test was used for comparison of categorical data between groups;the trend chi-square test was used for comparison of one-way ordinal categorical data,and the Goodman-Kruskal Gamma analysis was used for two-way ordinal categorical data.An ordinal logistic regression analysis was used to investigate the correlation between body mass index(BMI) and severity of AP,and a binary logistic regression analysis was used to investigate the correlation between MS and severity of AP.Results The most common causes of MS with AP were hyperlipidemia(48.3%) and biliary disease(24.7%).The patients with SAP were more likely to have MS(χ2=141.519,P<0.001),and the patients with AP and MS tended to have a significantly higher clinical system score,significantly more local and systemic complications,significantly longer hospital stays,a significantly higher ICU admission rate,and a significantly higher mortality rate(all P<0.05).The severity of AP increased with the increase in MS components(overweight,hypertension,diabetes,and dyslipidemia),(G=0.540,P<0.001).There were significant differences between the MAP,MSAP,and SAP groups in BMI(F=9.291,P<0.001) and high-density lipoprotein cholesterol(HDL-C)(χ2=40.351,P<0.001),and the SAP group had significantly higher BMI and significantly lower HDL-C than the MAP group and the MSAP group(all P<0.05).The ordinal logistic regression analysis showed that BMI was an independent risk factor for the progression of AP(odds ratio [OR]=1.091,95% confidence interval [CI]:1.041-1.143,P<0.001).Binary logistic regression models were established based on the severity of AP,with MAP group versus non-MAP group as model 1 and SAP group versus non-SAP group as model 2.The results showed that in model 1,the incidence rate of non-MAP was 5.867 times that of MAP in patients with MS(OR=5.867,95% CI:3.072-11.207,P<0.001),and in model 2,the incidence rate of SAP was 7.214 times that of non-SAP(OR=7.214,95% CI:3.018-17.244,P<0.001).Both model 1 and model 2 showed that HDL-C was a protective factor against the progression of AP(model 1:OR=0.593,95% CI:0.387-0.910,P=0.017;model 2:OR=0.314,95% CI:0.160-0.614,P=0.001).Conclusion AP with MS on admission may suggest poor prognosis,and BMI and HDL-C are closely associated with disease progression.
[1] Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association; Editorial Board of Chinese Journal of Pancreatology; Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis(Shenyang,2019)[J]. J Clin Hepatol,2019,35(12):2706-2711.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].临床肝胆病杂志,2019,35(12):2706-2711.
|
[2] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis—2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.
|
[3] Metabolic Syndrome Research Collaboration Group from Chinese Diabetes Society. Suggestions on metabolic syndrome from Chinese Diabetes Society[J]. Chin J Diabetes,2004,12(3):156-161.(in Chinese)中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161.
|
[4] PREZ-MARTNEZ P,MIKHAILIDIS DP,ATHYROS VG,et al. Lifestyle recommendations for the prevention and management of metabolic syndrome:An international panel recommendation[J]. Nutr Rev,2017,75(5):307-326.
|
[5] CORNIER MA,DABELEA D,HERNANDEZ TL,et al. The metabolic syndrome[J]. Endocr Rev,2008,29(7):777-822.
|
[6] SHEN XB,YIN Y. The relationship between metabolic syndrome and prognosis of patients with acute cerebral infarction[J]. Traum Crit Med,2019,7(3):184-186.(in Chinese)沈小波,殷艳.代谢综合征与急性脑梗死患者预后关系研究[J].创伤与急危重病医学,2019,7(3):184-186.
|
[7] DOBSZAI D,MTRAI P,GYNGYI Z,et al. Body-mass index correlates with severity and mortality in acute pancreatitis:A meta-analysis[J]. World J Gastroenterol,2019,25(6):729-743.
|
[8] SAWALHI S,AL-MARAMHY H,ABDELRAHMAN AI,et al.Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis? A prospective study[J].Pancreas,2014,43(4):565-570.
|
[9] KRISHNA SG,HINTON A,OZA V,et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis:A propensity-matched study[J]. Am J Gastroenterol,2015,110(11):1608-1619.
|
[10] GREGOR MF,HOTAMISLIGIL GS. Inflammatory mechanisms in obesity[J]. Annu Rev Immunol,2011,29(1):415-445.
|
[11] HENAO-MEJIA J,ELINAV E,JIN C,et al. Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity[J]. Nature,2012,482(7384):179-185.
|
[12] KHATUA B,EL-KURDI B,SINGH VP. Obesity and pancreatitis[J]. Curr Opin Gastroenterol,2017,33(5):374-382.
|
[13] VARELA JE,HINOJOSA M,NGUYEN N. Correlations between intra-abdominal pressure and obesity-related co-morbidities[J]. Surg Obes Relat Dis,2009,5(5):524-528.
|
[14] SADR-AZODI O,ORSINI N,ANDRN-SANDBERG A,et al. Abdominal and total adiposity and the risk of acute pancreatitis:A population-based prospective cohort study[J].Am J Gastroenterol,2013,108(1):133-139.
|
[15] DING Y,ZHANG M,WANG L,et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis[J]. Lipids Health Dis,2019,18(1):93.
|
[16] FREITAS RS,FONSECA MJMD,SCHMIDT MI,et al. Hypertriglyceridemic waist phenotype:Associated factors and comparison with other cardiovascular and metabolic risk indicators in the ELSA-Brasil study[J]. Cad Saude Publica,2018,34(4):e00067617.
|
[17] ZHANG Y,GUO F,LI S,et al. Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure,pancreatic necrosis and mortality in acute pancreatitis[J]. Sci Rep,2017,7(1):8064.
|
[18] ZHOU CL,ZHANG CH,ZHAO XY,et al. Early prediction of persistent organ failure by serum apolipoprotein A-I and high-density lipoprotein cholesterol in patients with acute pancreatitis[J]. Clin Chim Acta,2018,476:139-145.
|
[19] SILVA-VAZ P,ABRANTES AM,CASTELO-BRANCO M,et al. Multifactorial scores and biomarkers of prognosis of acute pancreatitis:Applications to research and practice[J].Int J Mol Sci,2020,21(1):e338.
|
[1] | Chan LI, Zhihai LIANG, Guodu TANG. Influencing factors for persistent inflammation, immunosuppression, and catabolism syndrome in patients with severe acute pancreatitis and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2023, 39(6): 1382-1390. doi: 10.3969/j.issn.1001-5256.2023.06.019 |
[2] | Qiu JIN, Jing YANG, Honglin MA, Pingju LI, Shaoshan HU, Qingqing LIU. Value of different scoring systems in predicting the severity and prognosis of hyperlipidemic acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2551-2557. doi: 10.3969/j.issn.1001-5256.2022.11.022 |
[3] | Qiu JIN, Jing YANG, Honglin MA, Pingju LI, Shaoshan HU, Qingqing LIU. Research advances in the value of related markers in predicting the severity and prognosis of acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(12): 2877-2881. doi: 10.3969/j.issn.1001-5256.2022.12.038 |
[4] | Yangyang XIONG, Dong WU, Jiaming QIAN. Role of gut microbiota and its metabolites in severe acute pancreatitis-related acute respiratory distress syndrome[J]. Journal of Clinical Hepatology, 2021, 37(1): 233-236. doi: 10.3969/j.issn.1001-5256.2021.01.052 |
[5] | Yuqing CHEN, Peiling LI, Lu ZHANG, Huan XU, Yan PENG, Xiaowei TANG. Clinical and prognostic features of hypertriglyceridemic pancreatitis during pregnancy[J]. Journal of Clinical Hepatology, 2021, 37(5): 1164-1168. doi: 10.3969/j.issn.1001-5256.2021.05.036 |
[6] | Huili WU, Hongbo SHI, Yanmin LIU, Mei DING, Zhenglai MA, Shuang LIU, Yu CHEN, Zhongping DUAN. Clinical features and prognosis of autoimmune hepatitis patients with different sexes[J]. Journal of Clinical Hepatology, 2021, 37(7): 1636-1643. doi: 10.3969/j.issn.1001-5256.2021.07.031 |
[7] | LV SuCong, ZHANG BaoZhong. Etiology,clinical manifestations,and prognosis of liver failure in pregnancy[J]. Journal of Clinical Hepatology, 2020, 36(12): 2756-2760. doi: 10.3969/j.issn.1001-5256.2020.12.023 |
[8] | Yan YongFeng, Jiang Xin, Zhong Rui, Xu Huan, Peng Yan, Tang XiaoWei. Clinical features and prognosis of acute pancreatitis with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(5): 1091-1096. doi: 10.3969/j.issn.1001-5256.2020.05.028 |
[9] | JIANG Xin, YAN YongFeng, ZHONG Rui, XU Huan, PENG Yan, TANG XiaoWei. Influence of serum triglyceride level on the prognosis of acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(11): 2509-2514. doi: 10.3969/j.issn.1001-5256.2020.11.022 |
[10] | An WenHui, He XuChang, Yang Jing, Ren BeiBei, Zhang Xue, Leng Jiao, Luo Run. Value of early admission scoring systems in predicting the severity and prognosis of acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(6): 1342-1346. doi: 10.3969/j.issn.1001-5256.2020.06.030 |
[11] | Bai JiDong, Xue RongQuan, Bai YongLe, Xia YiJun, Wang XiDong, Xi LongFu, Han XiaoYue, Han LiBo. Association between metabolic syndrome and gallstones[J]. Journal of Clinical Hepatology, 2020, 36(3): 701-703. doi: 10.3969/j.issn.1001-5256.2020.03.052 |
[12] | CHEN Huan, LI Ting, WANG ZiJie, WANG ZhongQiong, LUO Gang, DENG MingMing. Influence of metabolic syndrome and its components on the prognosis of patients with pancreatic cancer[J]. Journal of Clinical Hepatology, 2020, 36(12): 2788-2794. doi: 10.3969/j.issn.1001-5256.2020.12.029 |
[13] | LI XianQiu, LIU Hui, XIAO ChunTao, LUO Gang, ZHOU Xian. Influence of metabolic syndrome on patients with recurrence of hypertriglyceridemic acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(11): 2515-2520. doi: 10.3969/j.issn.1001-5256.2020.11.023 |
[14] | Yuan Jing, Meng Fei, Tang XiaoWei, Chen Xia, Peng Yan. Clinical features and prognosis of acute pancreatitis in pregnancy[J]. Journal of Clinical Hepatology, 2019, 35(1): 138-142. doi: 10.3969/j.issn.1001-5256.2019.01.026 |
[15] | Zhong Rui, Xu Huan, Peng Yan, Yan YongFeng, Jiang Xin, Wang Min, Fu WenGuang, Tang XiaoWei. Clinical and prognostic features of children with acute pancreatitis:A retrospective analysis of 105 cases[J]. Journal of Clinical Hepatology, 2019, 35(10): 2240-2245. doi: 10.3969/j.issn.1001-5256.2019.10.022 |
[16] | Jiang Xin, Xu Huan, Yan YongFeng, Zhong Rui, Luo XuJuan, Shi XiaoMin, Wang Min, Peng Yan, Tang XiaoWei. Clinical and prognostic features of acute alcoholic pancreatitis[J]. Journal of Clinical Hepatology, 2019, 35(11): 2528-2532. doi: 10.3969/j.issn.1001-5256.2019.11.027 |
[17] | Gao Fan, Qi XingShun, Hou Yue, Guo XiaoZhong. Association between pancreatitis and fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(1): 40-45. doi: 10.3969/j.issn.1001-5256.2017.01.008 |
[18] | Liu Jing, Shi JunPing. Diagnosis and treatment of hepatitis B virus infection complicated by metabolic syndrome[J]. Journal of Clinical Hepatology, 2016, 32(11): 2039-2042. doi: 10.3969/j.issn.1001-5256.2016.11.004 |
[19] | Niu ChunYan, Yan Rong, Tian Yu, Ma HuiXia, Jiao ShuJiang. The prevalence of fatty liver disease and its relationship with metabolic syndrome[J]. Journal of Clinical Hepatology, 2010, 26(2): 167-169. |
1. | 李晓蓉,姚家喜,施志斌. SAA、GRP78、miR-21-3p与老年急性胰腺炎Ranson和APACHEⅡ评分的关联性. 中国老年学杂志. 2025(05): 1092-1095 . ![]() | |
2. | 赵永红,陈爱荣,胡梦茹,王燚鑫,衣桂荣. 急性胰腺炎伴代谢综合征的临床特点和危险因素分析. 现代消化及介入诊疗. 2024(06): 664-669 . ![]() | |
3. | 宋小利,陈璐. 大剂量维生素C联合乌司他丁、生长抑素治疗急性胰腺炎的效果及对肝肾功能的影响. 临床医学研究与实践. 2024(28): 39-42 . ![]() | |
4. | 卢景涛,彭琼. 非酒精性脂肪性肝病诊断联合BISAP评分对急性胰腺炎严重程度的预测价值. 医学信息. 2023(04): 118-122 . ![]() | |
5. | 黄雯雪,陈春洁,孙艳. 急性胰腺炎相关危险因素、严重程度评估及临床护理研究进展. 中国基层医药. 2022(03): 473-476 . ![]() | |
6. | 刘国雄,匡桥贵,喻欣荷,刘访,王宇,俞洋,陈杨. 加味大承气汤治疗湿热蕴结型高脂血症性急性胰腺炎的疗效及作用机制. 中国实验方剂学杂志. 2021(05): 91-97 . ![]() | |
7. | 王婷婷,何家俊,杨楚婷,李圆浩,陈炜炜,刘军. 非酒精性脂肪性肝病与急性胰腺炎的关系. 临床肝胆病杂志. 2021(03): 729-732 . ![]() | |
8. | 赵冬雨,成丽娅,邵伟,马程,沈宏. 胰胆舒胶囊联合乌司他丁治疗急性胰腺炎的临床研究. 现代药物与临床. 2021(04): 712-716 . ![]() | |
9. | 黄莹,苗雨,林晚,刘昊,张飞雄,阮继刚. 急性复发性胰腺炎合并代谢综合征的临床特点及预后分析. 宁夏医学杂志. 2021(11): 968-971 . ![]() |